UCL Technology

UCL Business (UCLB) is the technology commercialisation company of University College London (UCL), serving as a bridge between academic research and the commercial market. As a wholly-owned subsidiary of UCL, the company is responsible for identifying, protecting, and commercialising intellectual property arising from the university's extensive research base. UCLB has a significant focus on the life sciences, having facilitated the creation of numerous high-profile spin-out companies in fields such as gene therapy, cell therapy, and oncology. Notable successes include the formation of companies like Autolus, MeiraGTx, and Orchard Therapeutics. In addition to spin-out creation, UCLB manages licensing agreements with global pharmaceutical partners and oversees the UCL Technology Fund. The company plays a vital role in the UK's biotech ecosystem, particularly within the London Golden Triangle of research excellence.